137278-71-8Relevant articles and documents
Design, synthesis and biological evaluation of spiropyrazolopyridone derivatives as potent dengue virus inhibitors
Chen, Haiying,Shi, Pei-Yong,Xie, Xuping,Xu, Jimin,Xue, Yu,Ye, Na,Zhou, Jia,Zou, Jing
, (2020/04/10)
The effective treatment for dengue virus infection continues to be a challenge. We herein reported our continued SAR exploration on the spiropyrazolopyridone scaffold. Introducing different substituents at the 3?- or 5?-site of the pyrazolopyridone core or moving the benzyl chain to the adjacent nitrogen led to a significant loss of potency on DENV-2. While a narrow range of substitutions were tolerated at the para-position of the phenyl ring, di-substitution on the phenyl ring is beneficial for DENV-2 potency and has variable influences on DENV-3 potency depending on the exact compound. Among these molecules, compounds 22 (JMX0376) with 4-chloro-3-fluorobenzyl and 24 (JMX0395) with 2,4-bis(trifluoromethyl)benzyl showed the most potent and broadest inhibitory activities against DENV-1 to ?3 with nanomolar to low micromolar EC50 values.
Lead optimization of spiropyrazolopyridones: A new and potent class of dengue virus inhibitors
Zou, Bin,Chan, Wai Ling,Ding, Mei,Leong, Seh Yong,Nilar, Shahul,Seah, Peck Gee,Liu, Wei,Karuna, Ratna,Blasco, Francesca,Yip, Andy,Chao, Alex,Susila, Agatha,Dong, Hongping,Wang, Qing Yin,Xu, Hao Ying,Chan, Katherine,Wan, Kah Fei,Gu, Feng,Diagana, Thierry T.,Wagner, Trixie,Dix, Ina,Shi, Pei-Yong,Smith, Paul W.
, p. 344 - 348 (2015/03/30)
Spiropyrazolopyridone 1 was identified, as a novel dengue virus (DENV) inhibitor, from a DENV serotype 2 (DENV-2) high-throughput phenotypic screen. As a general trend within this chemical class, chiral resolution of the racemate revealed that R enantiomer was significantly more potent than the S. Cell-based lead optimization of the spiropyrazolopyridones focusing on improving the physicochemical properties is described. As a result, an optimal compound 14a, with balanced in vitro potency and pharmacokinetic profile, achieved about 1.9 log viremia reduction at 3 × 50 mg/kg (bid) or 3 × 100 mg/kg (QD) oral doses in the dengue in vivo mouse efficacy model.
SPIROPYRAZOLOPYRIDINE DERIVATIVES AND USES THEREOF FOR THE TREATMENT OF VIRAL INFECTIONS
-
, (2014/10/29)
A compound of Formula (I) is provided that has been shown to be useful for treating a disease caused by a viral infection: (I) wherein R1, R2, R3, R4, R5, R6, R7, R8, X1, X2, X3 and X4, are as defined herein.
Synthesis of 7,8-Dihydro-6H-pyrazoloquinolin-5-ones and Related Derivatives
Gatta, Franco,Pomponi, Massimo,Marta, Maurizio
, p. 1301 - 1308 (2007/10/02)
This paper describes the synthesis of a new series of 4-amino-1-(unsubstituted and chloro or fluoro substituted benzyl)-7,8-dihydro-6H-pyrazoloquinolin-5-ones 8 and the corresponding 7,8-dihydro-6H,9H-pyrazoloquinoline-4,5-diones 13.The deri